Company intelligence / Profile preview

Quadrille Capital

Ownership: Private
Employees: ~30
Development stage: Other

Overview

Quadrille Capital is a Paris-based independent investment manager specializing in global growth equity and late-stage venture investments across technology and healthcare sectors. The firm manages over €1.6 billion in assets under management (AUM) and has invested both directly into high-growth companies—including those developing next-generation antibody therapies—and indirectly via commitments to leading VC funds. Its portfolio includes notable exits such as Freshly (acquired by Nestlé) and Expanse (acquired by Palo Alto Networks). In healthcare/biotech specifically, it has backed innovative firms like BigHat Biosciences.

Industry: Investors

Partnerships

Invests alongside top-tier VC/growth funds globallyCo-invests with other major investors

Beyond the preview

Go deeper on Quadrille Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Quadrille Capital.

Explore the full profile